DEVELOPING COUNTRIES AND IP: ACCESS TO HEALTH CARE EDUCATION MATERIALS Karen A. LeCuyer, Ph.D. University of Connecticut School of Law 30 May 2007.

Slides:



Advertisements
Similar presentations
GATT AND TRIPS.
Advertisements

UN-OHRLLS International support measures and financial resources for LLDCs Gladys Mutangadura UN-OHRLLS.
TRIPs and Public Health: The Unresolved Debate Tenu Avafia tralac
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Intellectual Property Rights, Investment and Transfer of Technology in the Pharmaceutical Sector Patrizia Carlevaro Head of the International Aid Unit.
The World Intellectual Property Organization (WIPO)
Differential pricing and access to medicines: issues and options Andrew Creese Essential Drugs and Medicines Policy Health Technology and Pharmaceuticals.
Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
Fostering R&D and Promoting Access to Medicines (for all) From Alma Ata, via Doha to Geneva (in 10 minutes) Bellagio, Italy October 2007 Ellen ‘t.
1 WTO and medicines: from Doha to Cancún Germán Velásquez Essential Drugs and Medicines Policy World Health Organization Geneva, October 2003.
Prize for TB low-cost point of care rapid diagnostic test Pierre Chirac Médecins Sans Frontières, Paris, France Campaign for Access to Essential Medicines.
J.P. Singh Georgetown University Communication, Culture, & Technology Program TRIPS: Negotiating Intellectual Property in the World Trading System J.
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
XIX International AIDS Conference July 2012 Washington DC, USA The Brazilian experience: the campaign for access to lopinavir/ritonavir and efavirenz compulsory.
The role of commercial enterprises in health Dr. Petra Laux, GSK Brussels September 2001.
Health Professional Students AIDS Advocacy Network Treat the People: Access to Essential AIDS Medications A Primer for Health Professional Students.
Describe the key policy measures that make globalization sustainable.
PRESENTED BY ELIZABETH TAMALE ASSISTANT COMMISSIONER MINISTRY OF TRADE, INDUSTRY AND COOPERATIVES AID FOR TRADE, INTELLECTUAL PROPERTY AND DEVELOPMENT-
Public health, innovation and intellectual property 1 |1 | WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Global Strategy and Plan.
Vilnius Lithuania BSc.: Biochemistry Neuropsychology J.D.: University of Oregon LL.M.:University College London Pacific Northwest National Laboratory.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
WIPO’s Strategies on Intellectual Property and Economic Development WIPO’s Strategies on Intellectual Property and Economic Development United Nations.
A very short introduction to patents & access to medicines.
TRIPS flexibilities and examples which resulted in reduced medicine prices: Model legislation and compulsory licensing in Brazil Juliana V. Borges Vallini.
- Sustaining creative diversity through cultural goods and services - A UNESCO Pilot Project
11 Bill & Melinda Gates Foundation Global Libraries Initiative April 2007.
The emergence of an Enforcement Agenda Intellectual Property Rights and Access to Essential Medicines: Challenges and Opportunities in Free Trade Agreement.
IPRs serving innovation BioVision April Bibliotheca Alexandrina Ahmed Abdel Latif International Centre for Trade and Sustainable Development.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
EPA Negotiations: Intellectual Property and Sustainable Development for ECOWAS Countries By Catherine Grant Director: Trade Policy Business Unity South.
IAS Members Working Together for a Stronger Health Workforce IAS General Members and Policy Meeting Sydney, 24 th July 2007.
International IP Regime and A2M : Role of BRICS K M Gopakumar TWN.
 .
Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?
Trade-related policies and access to medicines ICTSD Consultation on trade policy coherence and access to medicines Geneva November 7 th 2006,
Creative Commons & World Intellectual Property Organization Lucinda Jones WIPO iCommons Summit 2005 Harvard Law School June 26, 2005.
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
Zimbabwe CSOs TRIPS and Access to medicines Aulline Mabika-Chapisa.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Do Patents Make HIV/AIDS Medication Inaccessible to Patients in Sub-Saharan Africa? Abstract There has been debate surrounding the issue of patents and.
Sustainable Approaches to Opening Access to Medical Inventions James Love Wizards of OS Berlin 15 Sept 06.
© IFPMA 2009WIPO Open-ended Forum on Proposed Development Agenda Projects - 13/10/2009 IFPMA views on the strategic use of information for sustainable.
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
Intellectual Property Rights and Pharmaceuticals (Following Up the ‘Novartis case’ ) Background note prepared for PHM Vic Internet Workshop.
Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?
Agreement on TRIPS TRIPS Agreement  When the WTO was established, it led to 18 specific agreements to which all members need to adhere. Members necessarily.
TRIPS TRIPS is the Agreement on Trade Related Aspects of Intellectual Property Rights Framed within the WTO, by “consensus” Regulates intellectual property.
Tensions between Brazil and the United States
Trans-Pacific Partnership Agreement (TPP)
The WTO, International Trade. Plan INTRODUCTION, What is the WTO? 1. History, The multilateral trading system—past, present and future 2. The organization.
Access to medicines Elizabeth Holzer, Legal Policy Advisor A global and local - legal and health systems issues.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
© 2017 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
The Importance of IP in the Global Context Colloquium on IP Rights Bratislava 25 June 2012 John Tarpey Director of Communications.
JA Global Marketplace Name Title Company. JA Global Marketplace Session One Objectives: “X” Marks the Spot Define trade Explain why countries trade with.
Economic Vitality and Intellectual Property Rights Discussion at Hanyang University May 26, 2005.
TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.
Science & Technology for National Progress in African Region: Highlights of Regional Strategy and Action Professor Gabriel B. Ogunmola, FAS President,
Intellectual Property Negotiations Between the United States and Colombia, Peru and Equator for a Free Trade Agreement, Relating to Medicine James Love.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
TRADE NEGOTIATION ON PHARMACETICALS PRESENTED BY CHOGO,MALESO (092SIS10).
An example of a partnership is the Commonwealth Health Professions Alliance of which the CNF is a founding member. The CHPA is an alliance of Commonwealth.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
Intellectual Property Protection and Access to Medicines
PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES
Carnegie Institution of Washington
IP Protection under the WTO
Trade-related policies and access to medicines
Presentation transcript:

DEVELOPING COUNTRIES AND IP: ACCESS TO HEALTH CARE EDUCATION MATERIALS Karen A. LeCuyer, Ph.D. University of Connecticut School of Law 30 May 2007

Outline TRIPS, IP, and the WTO Doha Declaration: IP and Public Health Access to Health Care Information: HIV/AIDS Health care worker education Public education Strategies for Improving Access to Health Care Information in the Developing World

TRIPS Agreement: 1994 Sets out minimum standards for IP Patents, copyright, trademark, geographical indications, industrial designs, etc. Enforcement framework within international trade, enforced by the WTO Linkage between IP and international trade all nations participating in the WTO are required to adhere to IP standards in order to participate in non- IP trade issues

WTO and IP WTOs mission is to lower trade barriers and provide a platform for trade negotiations between its member countries Developed and developing nations benefit from WTO membership Administration of trade agreements Forum for negotiations and settling disputes

TRIPS and Developing Countries TRIPS has been criticized for not considering the needs of developing countries and forcing them to adhere to global IP standards Increased IP standards can negatively impact access to essential medicines in developing countries

TRIPS, Fair Use and Public Access Protectionist IP policies are a problem for developing nations as net importers of IP Doha Declaration of 2001 addresses circumvention of patent rights for access to essential medicines However, health care education and technology transfer are also critical for developing countries Copyright issues have not been explicitly addressed

Doha Declaration: IP and Public Health

The Doha Declaration Developing and less developed countries given additional time to comply with TRIPS Doha Declaration on the TRIPS Agreement and Public Health affirmed the rights of TRIPS members to protect public health and especially to promote access to medicines

Doha Declaration and TRIPS TRIPS Agreement does not and should not prevent members from taking measures to protect public health, Paragraph 5 Use, to the full, the provisions in the TRIPS Agreement, which provide flexibility for this purpose, Id. Member nations determine what is a national emergency- AIDS/HIV

Doha Declaration and AIDS Improved availability of HIV/AIDS medicines, particularly in Africa Circumvent patents with a compulsory license Problems Less developed countries lack ability/infrastructure to produce drugs Pharmaceutical companies have opposed licenses Access to drugs is not the only problem

Extension of Doha Principles Beyond Patents Language of the Doha Declaration suggests that the principles apply to IP, not patents Heath care as essential for sustained development Both health care provider and patient education are critical areas for extension of the Doha principles

WHO, IP and Public Health WHA Resolution on Intellectual Property and Public Health (2003) reaffirm the importance of public health Commission on Intellectual Property, Innovation, and Public Health (CIPIH), 2004 investment in the human resources and the knowledge base, especially the development of tertiary education

Access to Health Care Information Educational materials are a critical means for the international flow of ideas, information and knowledge Extension of Doha Principles to fair use in copyright for materials related to health care and technology transfer Strong IP protection in the developed world while assisting the developing world

Access to Health Care Information: HIV/AIDS Health care worker education Public education

Developing Countries and HIV/AIDS 38.6 million people with HIV in million lost their lives to AIDS in 2005 Sub-Saharan African countries such as Botswana and Lesotho have HIV infection rates approaching 25% of the population At least in Sub-Saharan African, many drug companies have reduced prices

Education of Health Care Workers Training in antiretroviral therapy and clinical strategies for patient management Need for continuing education, particularly in remote areas Digital media and Internet-based tools and information Providing materials in a culturally sensitive way

Public Health Care Education Lack of education is a risk factor for HIV infection Education programs developed in the United States have been shown to be effective in developing countries Use of simpler text and pictograms Digital media and Internet-based tools and information

Strategies for Improving Access Initiatives for improving access to educational materials and technology Creative Commons Open source A2K Support of nongovernmental agencies Foundations formed by pharmaceutical companies Bill & Melinda Gates Foundation Clinton Foundation

Creative Commons Authors retain some rights and dedicate others to the public License menu: Attribution License, Noncommercial License, Developing Nations License Science Commons Free access to scientific journals over the Internet

Open Source Movement Open source software: open source code Reverse engineer and develop Moving from open source to open access Positive: eliminate costs, creation of additive works Negative: removes economic incentives, open source materials subject to vandalism and/or misinformation

A2K Objective: protect and enhance [expand] access to knowledge, and to facilitate the transfer of technology to developing countries Unlike the Creative Commons, A2K IP standards are mandatory and not defined by the author

A2K and Copyright Make original works more affordably available, particularly for educational purposes Limit copyright protections to works that meet a creativity threshold

A2K and TRIPS TRIPS establishes minimum IP protections A2K establishes maximum IP protections A2K may foster the ability of developing nations to produce knowledge by making information more accessible

Nongovernmental Organizations Provide medicines as well as health care worker and public education NGOs are essential to identifying and reproducing best practices to work with HIV/AIDS

Pharmaceutical Companies SECURE THE FUTURE, Bristol-Myers Squibb Funds training for health care professionals as well as public health care education in Sub-Saharan Africa Botswana/Gates/Merck partnership Health care worker training, prevention initiative Positive Action Program, GlaxoSmithKline Education program for men in Kenya Corporate HIV/AIDS site- information for health care professionals

Bill & Melinda Gates Foundation Global Development and Global Health Provides no-cost access to computers, the Internet, and technology training in public libraries and reading rooms in Chile, Mexico, Botswana, Latvia, and Lithuania Fund public health and education strategies aimed at reducing the transmission of HIV, and the stigma associated with HIV/AIDS

The Clinton Foundation Clinton Foundation HIV/AIDS Initiative (CHAI) affordable treatment combined with care and prevention programs Use business-based procedures to integrate care, treatment and prevention Care Consortium of research and treatment institutions to allow real-time sharing of data and information

Summary Doha principles can be expanded beyond patents IP protection in the developed world need not be sacrificed to aid developing countries HIV/AIDS is a global health crisis that is at the forefront of efforts to increase access to knowledge worldwide Businesses can help by improving access to information and support of NGOs